The investigation found that drug companies aggressively raise prices to meet revenue targets, that drug companies targeted the U.S. market for higher prices than are set in other countries, and that drug companies were engaged in anti-competitive practices to keep prices high.
Raskin discusses findings on drug pricing and anti-competitive practices by pharmaceutical companies.
Share
More from Jamie Raskin
Do you feel the outrage of Renee Good and Alex Pretti? You don't belong on this committee. You should get the hell out of here!
I hope—and will do everything I can to guarantee—that Davey gets true due process and a fair trial on these absurdly trumped-up charges.
The political and financial corruption driving the Trump presidency is a civic emergency.
Other voices in this conversation
